2020
T67. TRAUMA IN AFFECTIVE AND NONAFFECTIVE PSYCHOSIS: ASSOCIATIONS AND DISSOCIATIONS WITH COGNITIVE FUNCTIONING IN CHILDHOOD AND ADULTHOOD
Mollon J, Knowles E, Mathias S, Rodrigue A, Koenis M, Pearlson G, Glahn D. T67. TRAUMA IN AFFECTIVE AND NONAFFECTIVE PSYCHOSIS: ASSOCIATIONS AND DISSOCIATIONS WITH COGNITIVE FUNCTIONING IN CHILDHOOD AND ADULTHOOD. Schizophrenia Bulletin 2020, 46: s256-s257. PMCID: PMC7234213, DOI: 10.1093/schbul/sbaa029.627.Peer-Reviewed Original ResearchAffective psychosis groupNon-psychotic psychiatric disordersPsychotic disordersAdult traumaPsychosis groupChildhood Trauma QuestionnaireChildhood traumaTrauma History QuestionnairePsychiatric disordersCognitive functioningLifetime traumaImportant risk factorCase-control studyNonaffective psychotic disordersNon-psychotic groupAffective psychotic disordersManifestation of psychosisChildhood neglectAfrican American adultsNeurodevelopmental impairmentMore lifetime traumasRisk factorsAffective psychosisNonaffective psychosisHistory questionnaireTrauma in Affective and Nonaffective Psychosis: Associations and Dissociations With Cognitive Functioning in Childhood and Adulthood
Mollon J, Mathias S, Knowles E, Rodrigue A, Pearlson G, Barrett J, Poldrack R, Blangero J, Glahn D. Trauma in Affective and Nonaffective Psychosis: Associations and Dissociations With Cognitive Functioning in Childhood and Adulthood. Biological Psychiatry 2020, 87: s458. DOI: 10.1016/j.biopsych.2020.02.1165.Peer-Reviewed Original Research
1996
CT measurement of suprasellar cistern predicts rate of cognitive decline in Alzheimer's disease
Aylward E, Rasmusson D, Brandt J, Raimundo L, Folstein M, Pearlson G. CT measurement of suprasellar cistern predicts rate of cognitive decline in Alzheimer's disease. Journal Of The International Neuropsychological Society 1996, 2: 89-95. PMID: 9375193, DOI: 10.1017/s135561770000093x.Peer-Reviewed Original ResearchConceptsSuprasellar cisternAlzheimer's diseaseAD patientsCT measuresQuantitative computed tomography (CT) measuresMini-Mental State Exam scoreCT measurementsComputed tomography measuresProbable Alzheimer's diseaseState Exam scoreBicaudate ratioBifrontal ratioNeurocognitive declineLateral ventricleThird ventricleCT scanTomography measuresCognitive declineCognitive functionPatientsAdaptive functioningDiseaseScansNeuropsychological measuresCognitive functioning
1991
Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography
Tune L, Brandt J, Frost J, Harris G, Mayberg H, Steele C, Burns A, Sapp J, Folstein M, Wagner H, Pearlson G. Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography. Acta Psychiatrica Scandinavica. Supplementum 1991, 83: 61-65. PMID: 1897377, DOI: 10.1111/j.1600-0447.1991.tb03111.x.Peer-Reviewed Original ResearchMeSH KeywordsAgedAlzheimer DiseaseAmphetaminesBlood GlucoseBrainCerebrovascular CirculationDeoxyglucoseDose-Response Relationship, DrugDrug Administration ScheduleFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedNeuropsychological TestsPhysostigminePilot ProjectsTomography, Emission-ComputedTomography, Emission-Computed, Single-PhotonConceptsCerebral glucose metabolismCerebral blood flowSingle photon emission tomographyPhoton emission tomographyPositron emission tomographyBlood flowEmission tomographyGlucose metabolismAlzheimer's diseaseRegional cerebral glucose metabolismSignificant clinical improvementCognitive functioningClinical improvementMost patientsIntravenous administrationPatientsDiseasePhysostigmineTomographyBrain activityPreliminary findingsMetabolismPronounced improvementPathophysiologyIllness